Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Singh will help drive expansion of Longhorn’s PrimeStore MTM, a sample collection device.
September 22, 2026
By: Patrick Lavery
Why This Matters: See our coverage of other industry executive team appointments and promotions here.
Longhorn Vaccines and Diagnostics announced Vijay Singh, PhD, as the new Chief Scientific Officer of the company’s Life Science Tools division.
Not only does Longhorn specialize in commercial-stage life science tools, but also in the Investigational New Drug (IND) enabling stage.
Singh’s responsibilities will primarily include driving expansion of Longhorn’s PrimeStore Molecular Transport Media (MTM), a sample collection device. The company says Singh will also work closely with existing and new customers and help drive new product development. He is also expected to be a key resource for Longhorn’s Vaccine and Antibody division.
These assignments build on Singh’s 15-plus years of scientific and operational experience in molecular diagnostics. He held progressive scientific leadership roles at HealthTrackRx, with his most recent post being Vice President of Research and Development.
Singh also authored or co-authored 20 peer-reviewed publications on molecular diagnostics and infectious disease, presenting that research at national conferences.
Interestingly, at HealthTrackRx, Singh’s team used PrimeStore MTM as the single collection device for all samples and pathogens. By doing this, Longhorn says, Singh was able to engineer high-throughput diagnostic frameworks and lead broad-automation systems, accelerating assay development.
Singh has also led high-profile commercial launches centered on polymerase chain reaction (PCR) technology. These include an FDA-authorized COVID-19 PCR platform, and industry’s first commercial Mpox PCR assay.
“We could not be more excited to welcome Vijay,” Longhorn President Jeff Fischer said, noting Singh’s prior relationship with Longhorn. “We came to know not only an exceptional scientist and laboratory leader, but someone we genuinely enjoy working with … Vijay understands the needs of clinical laboratories firsthand. We are already seeing both long-standing and new customers benefit from his scientific expertise, practical experience, and ability.”
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !